Index. B Bilateral salpingo-oophorectomy (BSO), 69
|
|
- Christopher Shepherd
- 5 years ago
- Views:
Transcription
1 A Advanced stage endometrial cancer diagnosis, 92 lymph node metastasis, 92 multivariate analysis, 92 myometrial invasion, 92 prognostic factors FIGO stage, 94 histological grade, 94, 95 histologic cell types, 94 intraperitoneal spread, 95 isthmus-cervix extension, 95 lymphovascular invasion, 95 myometrial invasion, 95 pelvic and para-aortic nodal metastasis, 96 ploidy and steroid receptors, 96 serous carcinoma, 94 serum levels, 92 stage III disease adjuvant chemotherapy, 99 hormonal therapy, 99 para-aortic radiation therapy, 98 risk factors, 97 surgery, systematic therapy, 98 stage IV disease chemotherapy, 99, 100 combination chemohormonal therapy, 103 cytoreductive surgery, 99 hormonal therapy, radiation therapy, 98, 101 tamoxifen and aromatase inhibitors, 103 surgical staging systems, tumor-node-metastasis, 92, 93 Aromatase inhibitors, 113 B Bilateral salpingo-oophorectomy (BSO), 69 C Chemotherapy advanced stage endometrial cancer, combined radiotherapy, 85 cytotoxic (see Cytotoxic chemotherapy) locoregional recurrence, 86 medical oncology, metastatic and relapsed disease, 86 MIS, 85 non-resectable disease, 7 palliative, 125 platinum-based, 84 85, 87 Ciliated cell carcinoma, 34 Clear cell carcinoma, Combination chemohormonal therapy, 103 Corpus cancer syndrome, 13 Cytoreductive surgery, 99 Cytotoxic chemotherapy carboplatin plus paclitaxel, cisplatin plus doxorubicin, 113, 115 cisplatin plus paclitaxel, 113, 115 metastatic disease and relapse, 86 platinum-based combination, 113 E Early-stage endometrial cancer extrafascial hysterectomy, 56 histology assessment, 56 laparoscopic surgery, 58 lymphadenectomy, omentectomy, 57 ovarian preservation, 57 Springer Nature Singapore Pte Ltd R. Patni (ed.), Current Concepts in Endometrial Cancer, DOI /
2 128 Early-stage endometrial cancer (cont.) pelvic and para-aortic lymphadenectomy, 56 peritoneal wash cytology, 56 radical hysterectomy, 57 randomized trials, 58 stage I disease extrauterine spread and relapse, 60 FIGO, 37 high risk, 68 intermediate risk, 68 low risk, 68 platinum-based chemotherapy, robotic hysterectomy, 81 RT, 124 surgical management, surgical treatment, 69 stage II disease radical hysterectomy, 57 robotic hysterectomy, 81 surgical treatment, 70 surgical staging, tumour stage, 56 uterus-confined disease, 56 vaginal hysterectomy, 58 Endocrine therapy disease progression, 110 megestrol acetate, 110 metastatic disease and relapse, 86 Endometrial cancer clinical examination, combination chemotherapy, 7 definition, 31 diagnosis chronic anovulation, 43 Color Doppler, 46 dilatation and curettage, 47 family history of malignancies, 44 guided biopsy, hysteroscopy, office endometrial biopsy, 44, 45 Pap smear, 44 postmenopausal bleeding, sonohysterography, 46 tamoxifen-induced cystic hyperplasia, 43 transvaginal ultrasound examination, FIGO grading, 32, 37 genetics of, 38 histological types, 31, 32 history, imaging studies, 5 immunohistochemistry of, incidence of, 42 locoregional recurrence, 7 MIS (see Minimally invasive surgery (MIS)) molecular categories, 8 pathophysiology macroscopy, 31 myometrial invasion, 31 obesity, 31 type I, 31 type II, 31 pelvic lymph node dissection, 6 pre-and postoperative radiotherapy, 5 pre-management workup, patients CECT, cervical stromal involvement, 49, 50 Doppler, 49 fertility-preserving therapy, 51 imaging accuracy, initial evaluation, 47, 48 magnetic resonance imaging, 49, 50 positron emission tomography, 51 superficial myometrial invasion, 49, 50 TVUS, 49 progestational therapy, 7 prognostic factors of, 37 retroperitoneal lymph nodes, 6 stages, 5, 48 symptoms, 42 tumor biology, 7 Endometrial intraepithelial neoplasia (EIN) schema, 22 benign, 20, 21 definitions, 20, 21 diagnostic criteria, 20, 21 hormonal treatment, 24 levonorgestrel-releasing intrauterine system, 24 malignant, 20 management of, 23 nonsurgical management, pathologic criteria, 20 premalignant, 20 progestin regimes, 24 Endometrioid adenocarcinoma ciliated cells, 34 clear cell carcinoma, epidemiologic characteristics, 32 grade 1, 32, 33 grade 3, 32, 34 morphologic patterns, 32 mucinous carcinoma, 35
3 proliferative phase endometrium, 32 SCC, 36 secretory phase endometrium, 34 serous carcinoma, 35 small cell carcinoma, 36 with squamous differentiation, transitional cell carcinoma, 36 tumour necrosis and grading, 32 undifferentiated carcinoma, 36 villoglandular carcinoma, 34 Epidemiology, endometrial cancer clinical staging, 17 controlled diet, 17 diabetic postmenopausal women, 17 early detection, 17 endometrial biopsies, 17 protective factors breastfeeding, 16 cigarette smoking, 16 coffee drinking, 16 diabetes mellitus, 16 hormonal IUDs, 16 hormone replacement therapy, concomitant progesterone, 16 intrauterine devices, 16 metformin, 16 oral contraceptive pills, 15, 16 physical exercises, 15, 16 weight loss, 15, 16 women on tamoxifen, 17 risk factors age dependent, 12, 13 assessment, 17 diabetes mellitus, 12, 13 diet, 12, 13 family history, 12 HNPCC, 12, 14 hyperoestrogenic states, 12, 14 hypertension, 12, 13 infertility, 12, 14 menstrual history, 12, 14 microsatellite instability, 15 molecular alterations, 12 obesity, 12, 13 oestrogen-producing tumours, 12, 14 parity, polycystic ovary syndrome, 12, 14 race, 12, 13 tamoxifen usage, pelvic hygiene, 12, 15 Estrogen replacement therapy (ERT), 14, 30 F Fertility-preserving therapy, 51 G Genetics, endometrial carcinoma, 38 H Hereditary nonpolyposis colorectal cancer (HNPCC), 14, 44, 68 Hormonal therapy, 7, 23, 86, aromatase inhibitors, 113 parenteral and oral drugs, 112 progestational agents, 112 tamoxifen, 112 Hyperplasia, endometrium EIN diagnostic schema, premalignant lesions, WHO schema complex hyperplasia, 20 complex hyperplasia with atypia, 20 glandular complexity, 20 nuclear atypia, 20 poor reproducibility, 20 simple hyperplasia, 20 simple hyperplasia with atypia, I International Federation of Gynecology and Obstetrics (FIGO) grading, 32, 37, 94 Intracavitary brachytherapy, 84 L Laparoscopic surgery cost-effectiveness, 58 vs. open surgery, 57, 123 vs. robotic surgery, 79, 80, 123 safety benefit, 58 Lymphadenectomy adjuvant therapy, 70 BSO, 69 distal boundary, 75 incidence, 59 indications, 60 inferior boundary, 76 intraoperative assessment, 59 lateral and proximal boundary, 75 limited survival benefit, 61 lymph node dissection, 61 pararectal and paravesical spaces, 76 pathological tumour grade, 59 patient s prognosis, 69 pelvic/para-aortic lymph node sampling, 25, 37, 56, 59 61, 76, 77, 87, 92, 96, 120, 123
4 130 Lymphadenectomy (cont.) randomized controlled trials, 61 robotic-assisted hysterectomy, 79, 81 role of, 123 sentinel node mapping, surgical staging, 70 surgico-pathologically staged cancer, survival benefit, tumour stage, 59 Lynch syndrome, 4, 12, 14, 44, 68 M Management, endometrial cancer description, 119 imaging in, 120 medical oncology, PubMed search, 120 radiation oncology adjuvant radiation, 124 radical radiation, 124 surgical oncology, Medical oncology adjuvant chemotherapy, hormonal therapy, 125 palliative chemotherapy, 125 Minimally invasive surgery (MIS) adjuvant treatment advanced disease, 86 chemotherapy and radiotherapy, 85 locoregional recurrence, 86 metastatic and relapsed disease, platinum-based chemotherapy, radiotherapy, 84, 85 risk stratification, 84, 85 vaginal recurrence, 86 anterior and posterior colpotomies, 76 bilateral pelvic lymphadenectomy, 76, 77 clinical use, clinicopathological types, 68 efficacy of laparoscopy, external radiation therapy, follow-up and long-term implications, 88 histological subtype, 68 lymph node metastases, 68 lymphovascular space invasion, 68 maximal surgical debulking, 83 medical comorbidity, 6 myometrial invasion, 68 ovarian pedicles, 76 para-aortic lymphadenectomy, 76, 77 pathological features, 6 preoperative preparation technique medications, 71 patient positioning, 73, 74 port placement, proctoclysis enema, 71 robotic instruments, 73, 74 zero-degree scope, 73 prognosis, robotic surgical systems, 70 71, stage I high risk, 68 intermediate risk, 68 low risk, 68 surgical treatment complication rate, 69 laparoscopy, 69 laparotomy, 68 for stage I, 69 for stage II, 70 tumor diameter, 68 uterine manipulator, 75 vesicouterine groove, 75 Mucinous carcinoma, 35 O Oestrogen-producing tumours, 12, 14 Office endometrial biopsy, 4, 44, 45, 47 P Palliative hormonal therapy, 125 Platinum-based chemotherapy, 84 85, 87 Polycystic ovary syndrome, 12, 14 Postmenopausal bleeding, 17, 22 23, Precancer diagnosis dilatation and curettage, 22 endometrial sampling and imaging, postmenopausal bleeding, 22 tumor markers, 23 Premalignant lesions assessment and management, 25 endometrial precancer classification, 20 hyperplasia classification systems (see Hyperplasia, endometrium) intraoperative assessment, 25 morcellation and endometrial ablation, 25 pathophysiology, 30 precancer diagnosis, supracervical hysterectomy, 25
5 surgical staging, 25 type 1 and 2 tumors, 20 vaginal hysterectomy, 25 Progestational therapy, 7, 112 R Radiation therapy (RT) advanced stage endometrial cancer stage III disease, 100 stage IV disease, 99, 103 chemotherapy, 85 MIS, tumor-directed, 97, 98 vaginal vault recurrences, 111 Recurrent endometrial cancer bevacizumab, 117 cytotoxic chemotherapy anterior exenteration, 113, 114 carboplatin plus paclitaxel, cisplatin plus doxorubicin, 113, 115 cisplatin plus paclitaxel, 113, 115 platinum-based combination, 113 diagnosis, 110 hormonal therapy aromatase inhibitors, 113 parenteral and oral drugs, 112 progestational agents, 112 tamoxifen, 112 isolated vaginal vault recurrences, second-line therapy, surgery role, 112 temsirolimus, 117 women, treatment, 110 Robotic-assisted surgery applications, 70 binocular stereoscopic 3D vision, 70 efficacy of, vs. laparoscopic surgery, 123 learning curve, limitations of, motion scaling and precision, 71 obesity, survival analysis, 80 S Secretory carcinoma, 34 Sentinel node mapping for uterine cancer, Serous carcinoma, 8, 15, 35, 37, 38, 87, 94, 102 Small cell carcinoma, 36 Squamous cell carcinoma (SCC), Surgical oncology early-stage/uterus-confined disease (see Early-stage endometrial cancer) fertility-preserving surgery, 121 lymphadenectomy, 123 lymph nodal disease nomograms, sentinel lymph node procedure, technique of laparoscopic vs. open surgery, 123 robotic vs. laparoscopic surgery, 123 Surveillance, epidemiology and end results (SEER) database abnormal uterine bleeding, 4 anti-aromatase agents, 3 aromatase inhibitor therapy, 3 hysteroscopy-guided biopsy, 4 immunohistochemical analysis, 3 lymphadenectomy, 62 precursor lesions, 3 reproductive trends, 2 survival trend, 2 timely assessment, 4 Women s Health Initiative, 3 T Tamoxifen, 112 induced cystic hyperplasia, 43 The Cancer Genome Atlas (TCGA), 8 Transitional cell carcinoma, 36 U Undifferentiated carcinoma, 36 Uterine sarcoma, 8, 43 V Vaginal brachytherapy (VBT), 7, 124 Vaginal-cervical Ahluwalia retractor-elevator (VCARE) uterine manipulator, 73 Vaginal vault recurrences, isolated pelvic exenteration, 111 radiation therapy, 111 tailored treatment approaches, Villoglandular carcinoma, 34 W WHO schema classification, 20, 29
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)
Chapter 2: Initial treatment for endometrial cancer (including histologic variant type) CQ01 Which surgical techniques for hysterectomy are recommended for patients considered to be stage I preoperatively?
More informationTOC NCCN Categories of Evidence and Consensus Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. Category 2A: Based upon lower-level evidence,
More informationEndometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.
Endometrial cancer Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology dr.mate.szabolcs@gmail.com Epidemiology Developing countries Cervical cancer is the most common gyn. malignant tumor
More informationOne of the commonest gynecological cancers,especially in white Americans.
Gynaecology Dr. Rozhan Lecture 6 CARCINOMA OF THE ENDOMETRIUM One of the commonest gynecological cancers,especially in white Americans. It is a disease of postmenopausal women with a peak incidence in
More informationGynecologic Malignancies. Kristen D Starbuck 4/20/18
Gynecologic Malignancies Kristen D Starbuck 4/20/18 Outline Female Cancer Statistics Uterine Cancer Adnexal Cancer Cervical Cancer Vulvar Cancer Uterine Cancer Endometrial Cancer Uterine Sarcoma Endometrial
More information3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates
J. Anthony Rakowski D.O., F.A.C.O.O.G. MSU SCS Board Review Coarse Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates Signs
More informationEndometrial Cancer. Incidence. Types 3/25/2019
Endometrial Cancer J. Anthony Rakowski DO, FACOOG MSU SCS Board Review Coarse Incidence 53,630 new cases yearly 8,590 deaths yearly 4 th most common malignancy in women worldwide Most common GYN malignancy
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX Site Group: Gynecology Cervix Author: Dr. Stephane Laframboise 1. INTRODUCTION 3 2. PREVENTION 3 3. SCREENING AND
More informationGynecologic Cancers. What is Gynecologic Cancer. Who is at risk for GYN cancer? 3/1/2018 1
What is Gynecologic Cancer Gynecologic Cancers Marge Ramsdell RN, MN, OCN Madigan Army Medical Center Any cancer that starts in a woman s reproductive organs Each GYN cancer is unique 5 main types Cervical
More informationENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre)
ENDOMETRIAL CANCER Updated Apr 2017 by: Dr. Jenny Ko (Medical Oncologist, Abbotsford Cancer Centre) Source: UpToDate 2017, ASCO/CCO/Alberta provincial guidelines, NCCN Reviewed by: Dr. Sarah Glaze (Gynecologic
More informationHitting the High Points Gynecologic Oncology Review
Hitting the High Points is designed to cover exam-based material, from preinvasive neoplasms of the female genital tract to the presentation, diagnosis and treatment, including surgery, chemotherapy, and
More informationEndometrial Cancer. Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines
Saudi Gynecology Oncology Group (SGOG) Gynecological Cancer Treatment Guidelines Endometrial Cancer Emad R. Sagr, MBBS, FRCSC Consultant Gynecology Oncology Security forces Hospital, Riyadh Epidemiology
More informationNew Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%
Uterine Malignancy New Cancer Cases By Site 2010 Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3% Cancer Deaths By Site 2010 Lung 26% Breast 15% Colo-Rectal 9% Pancreas 7%
More informationIndex. Cytoplasm, nonepithelial malignant tumor features 70
Accurette device 23 Adenosarcoma, differential diagnosis 80, 81 Arias-Stella reaction 65 Atypical endocervical cells 8 Atypical endometrial cells 8 Atypical glandular cells (AGC) 8, 9 Atypical glandular
More informationCase Scenario 1. History
History Case Scenario 1 A 53 year old white female presented to her primary care physician with post-menopausal vaginal bleeding. The patient is not a smoker and does not use alcohol. She has no family
More informationMichael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center
Michael G. Kelly, MD Gynecologic Oncologist University of Colorado Cancer Center 50 yo healthy postmenopausal female with BMI = 35 with screening PAP smear = AGUS. What is the next step? (1) Colposcopy
More information17 th ESO-ESMO Masterclass in clinical Oncology
17 th ESO-ESMO Masterclass in clinical Oncology Cervical and endometrial Cancer Cristiana Sessa IOSI Bellinzona, Switzerland Berlin, March 28 th, 2018 Presenter Disclosures None Cervical Cancer Estimated
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia I have nothing to disclose. Stefanie M. Ueda, M.D. Assistant Clinical Professor UCSF Division of Gynecologic Oncology Female Malignancies in the United States New
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer
THIS DOCUMENT North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer Based on WOSCAN CMG with further extensive consultation within NOSCAN UNCONTROLLED WHEN PRINTED DOCUMENT
More informationChapter 8 Adenocarcinoma
Page 80 Chapter 8 Adenocarcinoma Overview In Japan, the proportion of squamous cell carcinoma among all cervical cancers has been declining every year. In a recent survey, non-squamous cell carcinoma accounted
More informationARRO Case: Early-stage Endometrial Cancer
ARRO Case: Early-stage Endometrial Cancer Ankit Modh, MD (PGY-4) Faculty Advisor: Mohamed A Elshaikh, MD Department of Radiation Oncology Henry Ford Cancer Institute Case Presentation 70 y/o African American
More informationWhat s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden
What s (new) and Important in Reporting of Uterine Cancers Katherine Vroobel The Royal Marsden Maastricht Pathology 2018 Wednesday 20 th June Endometrioid adenocarcinoma High grade carcinomas (common)
More informationMPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?
MPH Quiz Case 1 Surgical Pathology from hysterectomy performed July 11, 2007 Final Diagnosis: Uterus, resection: Endometrioid adenocarcinoma, Grade 1 involving most of endometrium, myometrial invasion
More informationWhat is endometrial cancer?
Uterine cancer What is endometrial cancer? Endometrial cancer is the growth of abnormal cells in the lining of the uterus. The lining is called the endometrium. Endometrial cancer usually occurs in women
More informationPORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:
May 2016 Randomisation Checklist Form 1, page 1 of 2 Patient seqnr. Age at inclusion (years) Hospital: Eligible patients should be registered and randomised via the Internet at : https://prod.tenalea.net/fs4/dm/delogin.aspx?refererpath=dehome.aspx
More informationAdjuvant Therapies in Endometrial Cancer. Emma Hudson
Adjuvant Therapies in Endometrial Cancer Emma Hudson Endometrial Cancer Most common gynaecological cancer Incidence increasing in Western world 1-2% cancer deaths 75% patients postmenopausal 97% epithelial
More informationGynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0)
Gynaecology NSSG (Lancs & South Cumbria) Uterine Cancer Guidelines (V4.0) ** VALID ON DATE OF PRINTING ONLY all guidelines available on the Strategic Clinical Network website : GMLSC SCN Date first published
More informationPlease complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE
Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES PHYSICAL EXAMINATION CASE 1: FEMALE REPRODUCTIVE 3/5 Patient presents through the emergency room with
More informationRelapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.9.3861 Relapse Patterns and Outcomes Following Recurrence of Endometrial Cancer in Northern Thai Women RESEARCH ARTICLE Relapse Patterns and Outcomes Following
More informationGynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationCancer of the corpus uteri
DOI: 10.1002/ijgo.12612 FIGO CANCER REPORT 2018 Cancer of the corpus uteri Frédéric Amant 1,2,3, * Mansoor Raza Mirza 4 Martin Koskas 5 Carien L. Creutzberg 6 1 Division of Gynecologic Oncology, University
More informationGynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health
Gynecologic Cancer Care in the Age of Precision Medicine Gynecologic Cancers in the Age of Precision Medicine Controversies in Women s Health Lee-may Chen, MD Department of Obstetrics, Gynecology & Reproductive
More informationProf. Dr. Aydın ÖZSARAN
Prof. Dr. Aydın ÖZSARAN Adenocarcinomas of the endometrium Most common gynecologic malignancy in developed countries Second most common in developing countries. Adenocarcinomas, grade 1 and 2 endometrioid
More informationNorth of Scotland Cancer Network Clinical Management Guideline for Carcinoma of the Uterine Cervix
THIS DOCUMENT North of Scotland Cancer Network Carcinoma of the Uterine Cervix UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Prepared by A Kennedy/AG Macdonald/Others Approved by NOT APPROVED Issue date April
More informationJanjira Petsuksiri, M.D
GYN malignancies Janjira Petsuksiri, M.D Outlines Cervical cancer Endometrial cancer Ovarian cancer Vaginal cancer Vulva cancer 2 CA Cervix Epidemiology - Second most common female cancer Risk factors
More informationUpdates in Gynecologic Oncology. Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018
Updates in Gynecologic Oncology Todd Boren, MD Gynecologic Oncologist Chattanooga s Program in Women s Oncology Sept 8 th, 2018 COI I have no conflict of interest to report Endometrial Cancer: Risk Factors
More informationPort-Site Metastases After Robotic Surgery for Gynecologic Malignancy
SCIENTIFIC PAPER Port-Site Metastases After Robotic Surgery for Gynecologic Malignancy Noah Rindos, MD, Christine L. Curry, MD, PhD, Rami Tabbarah, MD, Valena Wright, MD ABSTRACT Background and Objectives:
More informationSarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru
Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma
More informationENDOMETRIAL CANCER: A GUIDE FOR PATIENTS
ENDOMETRIAL CANCER: A GUIDE FOR PATIENTS PATIENT INFORMATION BASED ON ESMO CLINICAL PRACTICE GUIDELINES This guide for patients has been prepared by Reliable Cancer Therapies (RCT) as a service to patients,
More informationRETROSPECTIVE RECORD REVIEW OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER AND CARCINOSARCOMA AT RAHIMA
RETROSPECTIVE RECORD REVIEW OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER AND CARCINOSARCOMA AT RAHIMA MOOSA MOTHER AND CHILD HOSPITAL RECEIVING TREATMENT AT CHARLOTTE MAXEKE JOHANNESBURG ACADEMIC HOSPITAL
More informationStaging and Treatment Update for Gynecologic Malignancies
Staging and Treatment Update for Gynecologic Malignancies Bunja Rungruang, MD Medical College of Georgia No disclosures 4 th most common new cases of cancer in women 5 th and 6 th leading cancer deaths
More informationShina Oranratanaphan, Tarinee Manchana*, Nakarin Sirisabya
Comparison of Synchronous Endometrial and Ovarian Cancers versus Primary with Metastasis RESEARCH COMMUNICATION Clinicopathologic Variables and Survival Comparison of Patients with Synchronous Endometrial
More informationThe new FIGO classification in endometrial carcinoma
The new FIGO classification in endometrial carcinoma Poster No.: C-1073 Congress: ECR 2012 Type: Educational Exhibit Authors: A. IGLESIAS CASTAÑON, M. Arias Gonzales, J. Mañas Uxó, 1 2 1 2 2 2 B. NIETO
More informationChemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Find Studies About Studies Submit Studies Resources About Site Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer The safety and scientific validity of this study is
More informationGYNECOLOGIC MALIGNANCIES: Ovarian Cancer
GYNECOLOGIC MALIGNANCIES: Ovarian Cancer KRISTEN STARBUCK, MD ROSWELL PARK CANCER INSTITUTE DEPARTMENT OF SURGERY DIVISION OF GYNECOLOGIC ONCOLOGY APRIL 19 TH, 2018 Objectives Basic Cancer Statistics Discuss
More informationNAACCR Webinar Series /7/17
COLLECTING CANCER DATA: UTERUS 2017 2018 NAACCR WEBINAR SERIES Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationIndex. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,
More informationImpact of Surgery Extent on Survival and Recurrence Rate of Stage ⅠEndometrial Adenocarcinoma
Hou et al. / Cancer Cell Research 3 (2014) 65-69 Cancer Cell Research Available at http:// http://www.cancercellresearch.org/ ISSN 2161-2609 Impact of Surgery Extent on Survival and Recurrence Rate of
More informationStaging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion
5 th of June 2009 Background Most common gynaecological carcinoma in developed countries Most cases are post-menopausal Increasing incidence in certain age groups Increasing death rates in the USA 5-year
More information29 Cancer of the Uterine Corpus
29 Cancer of the Uterine Corpus Robbert Soeters INTRODUCTION Malignancies affecting the uterine corpus are endometrial adenocarcinoma and uterine sarcomas. ENDOMETRIAL ADENOCARCINOMA Endometrial adenocarcinoma
More informationUTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE
UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE Case: Adenosarcoma with heterologous elements and stromal overgrowth o TAH, BSO, omentectomy, staging biopsies of cul-de-sac, bladder
More informationGynaecological Oncology Cases
Gynaecological Oncology Cases 1. Tamoxifen and the endometrium 2. Cancer and the older woman Dr Julie M Lamont Consultant Gynaecological Oncologist Epworth Freemasons Hospital 21 st April 2015 Mrs FS 66
More informationFERTILITY SPARING IN ENDOMETRIAL CANCER
FERTILITY SPARING IN ENDOMETRIAL CANCER Prof. Dr. Bülent Özçelik Erciyes University Medical Faculty Department of Obstetrics and Gynecology Gynecologic Oncology Unit Endometrial Cancer Most frequent gynecologic
More informationCitation for published version (APA): van Kruchten, M. (2015). Molecular imaging of estrogen receptors [Groningen]: University of Groningen
University of Groningen Molecular imaging of estrogen receptors van Kruchten, Michel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please
More informationARROCase: Locally Advanced Endometrial Cancer
ARROCase: Locally Advanced Endometrial Cancer Charles Vu, MD (PGY-3) Faculty Advisor: Peter Y. Chen, MD, FACR Beaumont Health (Royal Oak, MI) November 2016 Case 62yo female with a 3yr history of vaginal
More informationGynecological Cancers in Primary Care
Gynecological Cancers in Primary Care Nora M. Lersch MSN CRNP AOCNP Division of Gynecological Oncology Objectives Identify the incidence of ovarian, cervical, vulvar and endometrial cancer Identify common
More informationSummary CHAPTER 1. Introduction
Summary This thesis aims to evaluate the diagnostic work-up in postmenopausal women presenting with abnormal vaginal bleeding. The Society of Dutch Obstetrics and Gynaecology composed a guideline, which
More informationNewton Wellesley Hospital 2013
Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationAdenocarcinoma of the Endometrium: An Institutional Review
Pieter Baltens, 1580. Feast of St. George. From the collection of Dr. Gordon and Adele Gilbert of St. Petersburg, Florida. Adenocarcinoma of the Endometrium: An Institutional Review Denis Cavanagh, MD;
More informationMesonephric carcinoma of the uterine corpus: A report of two cases
ONCOLOGY LETTERS 11: 335-339, 2016 Mesonephric carcinoma of the uterine corpus: A report of two cases JIANGUO ZHAO 1,2, CAIYAN LIU 2, JI QI 2 and PENGPENG QU 2 1 Clinical College of Central Gynecology
More information7. Cytoreductive surgery in endometrial cancer and uterine sarcomas
Transworld Research Network 37/661 (2), Fort P.O. Trivandrum-695 023 Kerala, India Cytoreductive Surgery in Gynecologic Oncology: A Multidisciplinary Approach, 2010: 123-151 ISBN: 978-81-7895-484-4 Editor:
More informationCervical Cancer: 2018 FIGO Staging
Cervical Cancer: 2018 FIGO Staging Jonathan S. Berek, MD, MMS Laurie Kraus Lacob Professor Stanford University School of Medicine Director, Stanford Women s Cancer Center Senior Scientific Advisor, Stanford
More informationEndometrial cancer. Cathrine Holland
Endometrial cancer athrine Holland Abstract Endometrial cancers are the most common gynaecological malignancies in the UKwith approximately 4500 new cases occur each year and the incidence is rising. Increasingly
More informationEnterprise Interest None
Enterprise Interest None Cervical Cancer -Management of late stages ESP meeting Bilbao Spain 2018 Dr Mary McCormack PhD FRCR Consultant Clinical Oncologist University College Hospital London On behalf
More informationPRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT
PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT QUESTION #1 WHICH OF THE FOLLOWING IS NOT A RISK FACTOR FOR CERVICAL CANCER? A. HIGH RISK HPV B. CIGARETTE SMOKING C.
More informationThe Primary Squamous Cell Carcinoma of The Endometrium: A Case Report and Literature Review
May, 2018 2018; Vol2; Issue5 http://iamresearcher.online The Primary Squamous Cell Carcinoma of The Endometrium: A Case Report and Literature Review Ahmed Guennoun, Yousra Krimou, Chahrazad Bouchikhi,
More informationUTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS
Review Journal of Translational Medicine and Research, volume 19, no. 1-2, 2014 UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS N. Bacalbaæa 1, A. Traistaru 2, I. Bãlescu 3 1 Carol Davila University of Medicine
More information5 Mousa Al-Abbadi. Ola Al-juneidi & Obada Zalat. Ahmad Al-Tarefe
5 Mousa Al-Abbadi Ola Al-juneidi & Obada Zalat Ahmad Al-Tarefe Abnormal Uterine Bleeding (AUB) AUB is a very common scenario or symptom where women complain of menorrhagia (heavy and/or for long periods),
More informationCervical cancer presentation
Carcinoma of the cervix: Carcinoma of the cervix is the second commonest cancer among women worldwide, with only breast cancer occurring more commonly. Worldwide, cervical cancer accounts for about 500,000
More informationEndometrial Cancer in Thai Women aged 45 years or Younger
RESEARCH COMMUNICATION Endometrial Cancer in Thai Women aged 45 years or Younger Jitti Hanprasertpong 1 *, Suchada Sakolprakraikij 1, Alan Geater 2 Abstract The aim of this retrospective study was to clarify
More information6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention
6 Week Course Agenda Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention Lee-may Chen, MD Director, Division of Gynecologic Oncology Professor Department of Obstetrics, Gynecology
More informationSee NS R. Version Continue
dis RT ± No pro otherapy/rt National Comprehensive Cancer Network N0-1 Resectable tomy ain RI ne an N2 N3 ADJUVANT RT ± chemotherapy c See Margins Stage IIIB ( Surgery ± chemo (categ ±RT Thoracoto Version
More informationGynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer
Gynecologic Oncology Pre invasive vulvar, vaginal, & cervical disease Vulvar Cervical Endometrial Uterine Sarcoma Fallopian Tube Ovarian GTD Gynecologic Oncologist Surgery Chemotherapy Radiation Therapy
More informationCervical Cancer 3/25/2019. Abnormal vaginal bleeding
Cervical Cancer Abnormal vaginal bleeding Postcoital, intermenstrual or postmenopausal Vaginal discharge Pelvic pain or pressure Asymptomatic In most patients who are not sexually active due to symptoms
More information64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus
Case 6 64 YO lady THBSO for prolapse At gross : A 3 cm endometrial polyp in the fundus Numerous irregular, large glands with leaf-like pattern Large glands with broad-based papillary infolding into the
More informationEndometrial line thickness in different conditions.
Endometrial line thickness in different conditions 1 Endometrial thickens in response to Rising estrogen levels during the menstrual cycle and then shedding endometrial at the times of menses 2 The thickens
More informationGynecological Cancers
Gynecological Cancers Outline Ovarian Cancer Uterine (Endometrial) Cancer Cervical Cancer Vulvar Cancer Vaginal Cancer Overian Cancer Ovarian cancer is cancer that forms in the tissue of the ovary and
More informationVaginal intraepithelial neoplasia
Vaginal intraepithelial neoplasia The terminology and pathology of VAIN are analogous to those of CIN (VAIN I-III). The main difference is that vaginal epithelium does not normally have crypts, so the
More informationCase Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue
Case Scenario 1 Oncology Consult: Patient is a 51-year-old male with history of T4N3 squamous cell carcinoma of tonsil status post concurrent chemoradiation finished in October two years ago. He was hospitalized
More informationPage # 1. Endometrium. Cellular Components. Anatomical Regions. Management of SIL Thomas C. Wright, Jr. Most common diseases:
Endometrium Pathology of the Endometrium Thomas C. Wright Columbia University, New York, NY Most common diseases: Abnormal uterine bleeding Inflammatory conditions Benign neoplasms Endometrial cancer Anatomical
More informationMRI in Cervix and Endometrial Cancer
28th Congress of the Hungarian Society of Radiologists RCR Session Budapest June 2016 MRI in Cervix and Endometrial Cancer DrSarah Swift St James s University Hospital Leeds, UK Objectives Cervix and endometrial
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationCase 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst
Gynaecology Case Presentation Organ Imaging 2016 University of Toronto Sarah Johnson 39 year old female Clinical history: Assess right ovarian cyst Clinically diagnosed endometriosis Started fertility
More informationManagement of Endometrial Hyperplasia
Management of Endometrial Hyperplasia Green-top Guideline No. 67 RCOG/SGE Joint Guideline February 2016 Management of Endometrial Hyperplasia This is the first edition of this guideline.this is a joint
More informationInvasive Cervical Cancer: Squamous Cell, Adenocarcinoma, Adenosquamous
Note: If available, clinical trials should be considered as preferred treatment options for eligible patients (www.mdanderson.org/gynonctrials). Other co-morbidities are taken into consideration prior
More informationJMSCR Vol 05 Issue 11 Page November 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i11.78 A Histomorphological Study of Carcinoma
More informationC ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)
C ORPUS UTERI C ARCINOMA STAGING FORM CLINICAL Extent of disease before any treatment y clinical staging completed after neoadjuvant therapy but before subsequent surgery Tis * T1 I T1a IA NX N0 N1 N2
More informationJacqui Morgan March 6, 2019
Jacqui Morgan March 6, 2019 Case 1 25yo, G2P1 Here for WWE, no problems, healthy, needs refill on OCPs. Pap- Abnormal Glandular Cells-NOS Now What?? Case 1 Colposcopy What findings? Case 1 ECC Cervical
More informationGynecologic Oncology update
Gynecologic Oncology update Park City Utah Postgraduate Course in the Department of Obstetrics and Gynecology University of Utah/Huntsman Cancer Institute Andrew P. Soisson, MD Division of Gynecologic
More informationRetrospective evaluation of clinical and pathological features, as well as diagnostic and treatment protocols of primary vaginal malignancy
ORIGINAL PAPER / GYNECOLOGY Ginekologia Polska 2016, vol. 87, no. 8, 541 545 Copyright 2016 Via Medica ISSN 0017 0011 DOI: 10.5603/GP.2016.0041 Retrospective evaluation of clinical and pathological features,
More informationFemale genital tract II.
Female genital tract II. Pathology of the uterine corpus Lilla Madaras 2 nd Department Of Pathology Semmelweis University Budapest 9 th April 2018 Anatomy 2 The normal endometrium Histology Regulation
More informationPathology of the female genital tract
Pathology of the female genital tract Common illnesses of the female genital tract Before menarche Developmental anomalies Tumors (ovarial teratoma) Amenorrhea Fertile years PCOS, ovarian cysts Endometriosis
More informationRitu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University
Cervical Cancer Ritu Salani, M.D., M.B.A. Assistant Professor, Dept. of Obstetrics & Gynecology Division of Gynecologic Oncology The Ohio State University Estimated gynecologic cancer cases United States
More informationbleeding Studies naar de diagnostiek van endom triumcarcinoom bij vrouwen met postm nopauzaal bloedverlies. Studies on the
Studies on the diagnosis of endometria cancer in women with postmenopausal bleeding. Studies naar de diagnostiek va endometriumcarcinoom bij vrouwen m postmenopauzaal bloedverlies. Studies on the diagnosis
More informationMANAGEMENT OF CERVICAL CANCER
MANAGEMENT OF CERVICAL CANCER Dr. Ujeen Shrestha Malla* and Prof. Dr. Zhang Shui Rong Department of Obstetrics and Gynaecology, Clinical Medical College of Yangtze University, Jingzhou Central Hospital,
More informationIt is a malignancy originating from breast tissue
59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast
More informationENDOMETRIAL CANCER. Endometrial cancer is a great concern in UPDATE. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. UPDATE ENDOMETRIAL CANCER Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationRadiation Oncology MOC Study Guide
Radiation Oncology MOC Study Guide The following study guide is intended to give a general overview of the type of material that will be covered on the Radiation Oncology Maintenance of Certification (MOC)
More information